Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PASW
PASW logo

PASW News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PASW News

ZIM Integrated Shipping Shares Surge 38.1% in Pre-Market Trading

Feb 17 2026Benzinga

Heritage Global Inc (HGBL) Acquires Debt Exchange Assets, Shares Surge 19.1%

Jan 13 2026Benzinga

Dow Jones Falls Over 250 Points as Financial Stocks Decline

Jan 12 2026Benzinga

Bark Inc (BARK) Shares Surge 19.9% on Acquisition Proposal from Great Dane

Jan 12 2026Benzinga

Ping An Bio Invests $60M in Future Biotechnology Group

Jan 09 2026Globenewswire

Ping An Bio Secures Strategic Investments from Key Industry Leaders to Enhance R&D Capabilities

Jan 09 2026Globenewswire

Ping An Biomedical Receives Nasdaq Minimum Bid Price Deficiency Notice

Nov 28 2025Globenewswire

Ping An Biomedical Receives Nasdaq Minimum Bid Price Deficiency Notice

Nov 28 2025Newsfilter

PASW Events

03/19 10:20
Ping An Biomedical Shareholders Approve Capital Structure Overhaul
Ping An Biomedical announced that shareholders have approved all five resolutions at the company's 2026 Annual General Meeting, providing full authorization for an overhaul of its share capital structure, the introduction of high-vote Class B shares, a targeted share exchange with a major shareholder, and a large-scale share consolidation. Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended in the manner and sequence set out below with immediate effect: increasing the authorised share capital $50,000 divided into 800,000,000 ordinary shares of a nominal or par value of $0.0000625 each to $312,500 divided into 5,000,000,000 ordinary shares of a par value $0.0000625 each, by the addition of 4,200,000,000 ordinary shares of a par value $0.0000625 each; re-designating and re-classifying 4,900,000,000 authorised ordinary shares of a par value $0.0000625 each as 4,900,000,000 class A ordinary shares of par value $0.0000625 each, where the rights of the existing ordinary shares shall be the same as the Class A Shares; cancelling 100,000,000 authorised but unissued ordinary shares of a par value $0.0000625 each and create a new share class of 100,000,000 class B ordinary shares of par value $0.0000625 each, which will be entitled to one hundred votes per share, such that the authorised share capital of the Company shall become $312,500 divided into 4,900,000,000 class A ordinary shares of a par value $0.0000625 each and 100,000,000 class B ordinary shares of a par value $0.0000625 each. Shareholders resolved by a special resolution that the second amended and restated memorandum and articles of association of the Company, in the substantial form attached to the notice of annual general meeting and the proxy statement as Appendix 1 be adopted in substitution for and to the exclusion of the existing memorandum and articles of association of the Company in its entirety with effect upon the Authorised Share Capital Changes taking effect. Shareholders resolved by an ordinary resolution that, subject to the Authorised Share Capital Changes and Second Amended MAA taking effect and the Company's receipt of the consent to repurchase and application for shares duly executed by INSPIRETECH, the Board be and is hereby authorised to repurchase 12,250,000 Class A Shares from INSPIRETECH, all of which are fully paid shares, in consideration of and out of the proceeds of the Company's new issuance of 12,250,000 Class B Shares to INSPIRETECH. The arrangement effectively converts part of INSPIRETECH's holding into high-vote shares while keeping the number of shares held by that shareholder unchanged. Shareholders resolved by an ordinary resolution that, following the Authorised Share Capital Changes, and conditional upon the approval of the Board, with effect on a date within one calendar year after the conclusion of the Meeting to be determined by the Board: every one thousand then issued and unissued Class A Shares, or such lesser whole share amount of not being less than two as the Board may determine in its sole discretion, be consolidated into one class A ordinary share, where such Consolidated Class A Shares shall rank pari passu in all respect with each other and have the same rights and are subject to the same restrictions as the existing Class A Shares as set out in the Second Amended MAA; every one thousand then issued and unissued Class B Shares, or such lesser whole share amount of not being less than two as the Board may determine in its sole discretion, be consolidated into one class B ordinary share, where such Consolidated Class B Shares shall rank pari passu in all respect with each other and have the same rights and are subject to the same restrictions as the existing Class B Shares as set out in the Second Amended MAA. Shareholders resolved by a special resolution that subject to and immediately following the Share Consolidation being effected, the relevant provisions of the memorandum and articles of association of the Company then in effect be amended to reflect the Share Consolidation.
02/13 17:00
Ping An Biomedical Files to Sell 13.61M Ordinary Shares
Ping An Biomedical Co. files to sell 13.61M ordinary shares for holders
01/09 09:40
Ping An Biomedical Enters Investment Memorandum with Future Biotechnology Group
Ping An Biomedical entered into a non-binding memorandum with Future Biotechnology Group. The Investment Memorandum outlines an initial investment of $30M to be paid in cash, as well as subsequent acquisitions with a consideration, in aggregate, of $60M to be settled in cash and share issuances. The Consideration Shares are to be held escrow and released in accordance with performance targets over an evaluation period of 3 years from January 2026 to December 2028.
01/09 07:20
Ping An Biomedical Enters Share Purchase Agreements with Multiple Investors
Ping An Biomedical has entered into a series of share purchase agreements with several investors: Yao Jinbo, Chairman and CEO of 58 Group; Wang Donghui, Founder and Managing Partner of Amiba Capital; and Li Daxue, Chairman and CEO of Magcloud Group and former Senior Vice President of JD.com and its Lifetime Honorary Advisor.

PASW Monitor News

Ping An Biomedical Co Ltd surges on technical breakout

Jan 21 2026

Ping An Biomedical Co Ltd reaches 20-day high amid market strength

Jan 09 2026

Technical Analysis and Market Performance of Ping An Biomedical Co Ltd

Nov 25 2025

PASW Earnings Analysis

No Data

No Data

People Also Watch